glp 1 agonist vs sglt2 inhibitor Cardiorenal Protection: Potential of Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes | Diabetes Therapy SGLT-2 Inhibitors and GLP-1 Agonists:

Additionally, factors secreted by retinal cells, like IL-6, promote the proliferation of different retinal cell types, contributing to the formation of new blood vessels and the progression of diabetic retinopathy (84)

Exendin-4, identified in 1992 from lizard venom, shares approximately 53% sequence similarity with human GLP-1

Common Side Effects Common side effects include: Nausea: This is one of the most frequently reported side effects

Within a year, he lost 30 more pounds, stopped one blood pressure medication, and reached an A1C of 5.5%

doi: 10.1210/jcem.76.4.8473405 [DOI] [PubMed] [Google Scholar] 73.Weber MM

Alzheimers Dement (2022) 18:70089